| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
27,845.85
|
|
Change (%)
|
-20.45 (-0.07%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
27,695.00
-
27,999.50
|
|
52-Week Range (RS)
|
25,164.00
-
34,220.00
|
|
Beta (1 Year)
|
NA
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Abbott India Ltd gains for fifth session |
| Abbott India Ltd drops for fifth straight session |
| Abbott India to convene AGM |
| Board of Abbott India recommends final dividend |
| Board of Abbott India recommends special dividend |
| Abbott India standalone net profit rises 7.60% in the March 2026 quarter |
| Abbott India clocks PAT of Rs 394.93 crore in March'26 quarter |
| Abbott India to discuss results |
| Abbott India standalone net profit rises 4.21% in the December 2025 quarter |
| Abbott India Q3 PAT jumps 4% YoY to Rs 376 cr |
|
|
|
| Incoporation Year : 1944 |
| Chairman : Munir Shaikh |
| Ownership Group : MNC Asc-Abbott |
| Sector : MAN |
| Industry : Pharmaceuticals - Multinational |
| Registered Office |
Abbott India Ltd Unit No 3 Corporate Park, Sion Trombay Road Chembur, Mumbai, Maharashtra-400071 |
Phone:91-22-67978888/50461000/2000/1119 Fax:91-22-50169400 |
| E-Mail : investorrelations.india@abbott.com; webmaster@abbo |
| URL : http://www.abbott.co.in |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
28-Jul-2026 |
27907.05 |
-0.22 |
| 1Month |
06-Jul-2026 |
26851.80 |
3.70 |
| 3Month |
04-May-2026 |
25426.70 |
9.51 |
| 6Month |
04-Feb-2026 |
27117.85 |
2.68 |
| 1Year |
04-Aug-2025 |
34040.05 |
-18.20 |
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| SBI Large & Midcap Fund |
1.92 |
783.55 |
| AXIS Midcap Fund |
1.23 |
414.29 |
| Canara Robeco Large and Mid Cap Fund |
1.40 |
352.58 |
| Nippon India Multi Cap Fund |
0.59 |
322.26 |
| Nippon India Pharma Fund |
2.09 |
189.12 |
|
|
|
| Groups : Pharmaceuticals - Multinational |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Glaxosmithkline Pharmaceuticals Ltd |
2,647.45 |
-0.37 |
2,935.85 |
2,088.00 |
44,849.40 |
| Pfizer Ltd |
4,864.80 |
-1.03 |
5,878.55 |
4,361.00 |
22,255.36 |
| Astrazeneca Pharma India Ltd |
8,173.90 |
-1.47 |
9,850.00 |
7,630.00 |
20,434.75 |
| Procter & Gamble Health Ltd |
6,480.35 |
-0.16 |
6,955.00 |
4,699.70 |
10,756.98 |
| Sanofi Consumer Healthcare India Ltd |
4,532.85 |
-0.08 |
5,493.10 |
3,950.50 |
10,439.44 |
|
|
|
|